GILD logo
Gilead Sciences, Inc.(GILD)
Closing price · checked 12:24 AM EDTAbout this dataData status
$153.07▼-3.12 (-2.00%)Earnings · Oct 29
Extended:$153.27+0.20 (+0.13%)

GILD EBITDA

$1.33BTTM · USD

Period ending:

GILD FY EBITDAUSD
GILD FY EBITDA1990-12-31: -$4.00M1991-12-31: -$5.30M1992-12-31: -$16.50M1994-12-31: -$31.30M1995-12-31: -$28.80M1996-12-31: -$31.60M1997-12-31: -$56.90M1998-12-31: -$65.10M1999-12-31: -$39.10M2000-12-31: -$40.31M2001-12-31: -$106.00M2002-12-31: $95.44M2003-12-31: $350.78M2004-12-31: $651.80M2005-12-31: $1.14B2006-12-31: $1.68B2007-12-31: $2.22B2008-12-31: $2.89B2009-12-31: $3.78B2010-12-31: $4.29B2011-12-31: $4.16B2012-12-31: $4.25B2013-12-31: $4.86B2014-12-31: $16.32B2015-12-31: $23.45B2016-12-31: $19.22B2017-12-31: $15.93B2018-12-31: $10.31B2019-12-31: $7.56B2020-12-31: $4.13B2021-12-31: $11.33B2022-12-31: $8.85B2023-12-31: $10.50B2024-12-31: $4.43B2025-12-31: $13.58B$23.45B-$106.00M
1990-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

GILD ebitda history

Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 35 observations from Dec 31, 1990 to Dec 31, 2025.

Gilead Sciences EBITDA — Annual fiscal periods (USD)
Period endingEBITDA (USD)
13,580,000,000
4,434,000,000
10,496,000,000
8,852,000,000
11,329,000,000
4,133,000,000
7,559,000,000
10,305,000,000
15,933,000,000
19,219,000,000
23,445,000,000
16,318,000,000
4,860,000,000
4,251,000,000
4,158,654,000
4,287,986,000
3,784,562,000
2,893,552,000
2,215,786,000
1,682,582,000
1,144,844,000
651,795,000
350,783,000
95,435,000
-105,998,000
-40,310,000
-39,100,000
-65,100,000
-56,900,000
-31,600,000
-28,800,000
-31,300,000
-16,500,000
-5,300,000
-4,000,000

Compare ebitda

Other companies in Healthcare. Each page shows its own reporting periods and currency.

All GILD financial metrics · GILD stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.